Glucocorticoid induced adrenal suppression in the UK and Ireland

  • Research type

    Research Study

  • Full title

    Symptomatic glucocorticoid induced adrenal suppression in the United Kingdom and Ireland

  • IRAS ID

    254207

  • Contact name

    Tim Cheetham

  • Contact email

    tim.cheetham@nhs.net

  • Sponsor organisation

    The Newcastle upon Tyne Hospitals NHS Foundation Trust

  • Duration of Study in the UK

    2 years, 0 months, 31 days

  • Research summary

    Glucocorticoids (GC) are steroid hormones made by the adrenal glands that sit above the kidneys. Natural GCs are essential to keep the body working normally and to deal with the stress of trauma and infections.

    GC medication is frequently used to treat diseases in children. GC medication can be applied to the skin, inhaled or swallowed as part of the treatment of many conditions such as eczema, asthma or arthritis. If the body absorbs large amounts of GC medication, then this can prevent the person from making natural GC. This inability to produce natural GC normally is called adrenal suppression (AS).

    AS is a particular concern at the time of infection when extra natural GC would normally be produced by the body as part of the stress response. If additional GC is not administered at such times in patients with AS then they can become unwell with symptoms and signs such as nausea, vomiting, low blood pressure, low glucose and altered consciousness. This is referred to as an adrenal crisis and can be fatal. Health professionals and patients do not always remember that GC medicine can prevent natural GC production and that additional GC may be needed when someone is unwell. This inability to make natural GC normally can persist if someone has recently stopped GC medicine. We intend to look at how common it is for children to present unwell at hospital because of AS. This will help us to develop ways of preventing adrenal crises and manage patients more effectively and safely.

  • REC name

    North West - Preston Research Ethics Committee

  • REC reference

    19/NW/0627

  • Date of REC Opinion

    9 Oct 2019

  • REC opinion

    Favourable Opinion